规格: | 98% |
分子量: | 345.39 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
Background:
Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment[1].
[1]. Glenmark's molecule for neuropathic pain, osteoarthritis - GRC 10693, successfully completes Phase I trials.
Protocol:
CB2
|